Jr. Wingard et Gj. Elfenbein, HOST IMMUNOLOGICAL AUGMENTATION FOR THE CONTROL OF INFECTION, Infectious disease clinics of North America, 10(2), 1996, pp. 345
The emergence of resistance to pharmacologic antimicrobial agents and
the desire to increase chemotherapy dose-intensity have necessitated t
he search for alternative means to control infectious disease. Enhance
ment of host immunity against infection has been permitted through the
use of hematopoietic growth factors, which can shorten the duration o
f neutropenia and reduce the risk for bacterial and fungal infections.
Hematopoietic growth factor-mobilized hematopoietic stem cells have a
lso proven to be highly efficacious in permitting high-dose chemothera
py. Interferons, immunoregulatory cytokines, immune globulins, and imm
une lymphocytes also hold promise to enhance host immunity and reduce
susceptibility for serious infectious morbidity.